Tech Company Financing Transactions

General Proximity Funding Round

General Proximity, based in San Francisco, received $9 million from Cancer Prevention and Research Institute of Texas (CPRIT).

Transaction Overview

Company Name
Announced On
11/20/2026
Transaction Type
Debt
Amount
$9,000,000
Round
Undisclosed
Proceeds Purpose
This award will help us move our lead program generated by OmniTAC into the clinic.

Company Information

Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
135 Mississippi Street
San Francisco, CA 94107
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
We've assembled a world-class team of proximity scientists from Scripps, the Broad Institute, Harvard, MIT, Yale, Oxford, and UCSF, with industry experience across top pharma and biotech institutions such as Lilly, Novartis, AbbVie, Bristol Myers Squibb, Amgen, Genentech, Roche, Alnylam, and Arvinas.
Profile
General Proximity LinkedIn Company Profile
Social Media
General Proximity Company Twitter Account
Company News
General Proximity News
Facebook
General Proximity on Facebook
YouTube
General Proximity on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Armand Cognetta
  Armand Cognetta LinkedIn Profile  Armand Cognetta Twitter Account  Armand Cognetta News  Armand Cognetta on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/20/2026: SCRYPT venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary